Atlas Trials

NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer

Clinical trial NCT02030561 · UNKNOWN

Trial details

NCT number
NCT02030561
Sponsor
National University Hospital, Singapore
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast CancerGastric Cancer
Start date
2014-01-01
Primary completion
2017-08-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.